AFCC has partnered with NutraBloom, which offers expertly-formulated supplements to support your health and fertility. Learn more.
AFCC has partnered with NutraBloom, which offers expertly-formulated supplements. Learn more.

Progesterone Withdrawal Test – Progesterone Challenge A Diagnostic Test for Secondary Amenorrhea

Progesterone Withdrawal Test – Progesterone Challenge A Diagnostic Test for Secondary Amenorrhea

  • The progesterone challenge test is is also referred to as a progestin challenge
  • It is done by givng a progestin medication and seeing if this induces a menstrual period
  • This same protocol of giving a progestin is often used to induce a period in women with irregular periods:
    • if she has not had a period for a while
    • if she skipped a period

How the Test Works

The progesterone challenge test is done by giving oral medroxyprogesterone acetate (Provera) 10 mg daily for 5-10 days or one intramuscular injection of 100-200 mg of progesterone in oil.

A positive response is any bleeding more than light spotting that occurs within 2 weeks after the progestin is given. This bleeding will usually occur 2-7 days after the progestin is finished.

Withdrawal bleeding will usually be seen if the patient’s estradiol level has been over about 40 pg/ml.

Possible Outcomes of the Test

  • If the patient experiences bleeding after the progestin she has estrogen present but is not ovulating (anovulation).
  • If no withdrawal bleeding occurs, either the patient has very low estrogen levels or there is a problem with the outflow tract such as uterine synechiae (adhesions) or cervical stenosis (scarring).

Women with Withdrawal Bleeding

  • The test has demonstrated that she builds up a lining in the uterus.
  • She bleeds after progesterone is withdrawn – showing that it is the lack of ovulation that is causing her not to have periods.

Possible Diagnoses for Women with Withdrawal Bleeding

Women without Withdrawal Bleeding

Possible Diagnosis

  • Hypothalamic hypoestrogenism (low estrogen levels)
  • Compromised outflow tract – either Asherman’s syndrome (adhesions) or cervical stenosis (scarring)
  • Premature ovarian failure

The Next Step: Give Estrogen and Progestin to Distinguish Between Hypoestrogenism or an Outflow Tract Obstruction (Asherman’s Syndrome or Cervical Stenosis)

Give estrogen to ensure endometrial proliferation, followed by a progestin to induce withdrawal bleeding. A course of 2.5 mg of Premarin for 21 days including 10 mg of Provera on days 17-21 should be adequate.

  • If bleeding occurs, amenorrhea is due to hypoestrogenism (hypothalamic amenorrhea or premature ovarian failure).
  • If bleeding does not occur, then most likely it is an outflow tract obstruction – either Asherman’s syndrome or cervical stenosis.
Share on facebook
Share on twitter
Share on linkedin

Related Articles

The site uses cookies, pixels and other similar technologies, as further described in our privacy statement. By using our site, you agree to our use of cookies.